Il6ra Phenotype Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Il6ra
interleukin 6 receptor, alpha
MGI:105304

36 phenotypes from 7 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Il6ra^{em1(IMPC)Wtsi}/Il6ra^{em1(IMPC)Wtsi} C57BL/6N-Il6ra^{em1(IMPC)Wtsi}/Wtsi	increased red blood cell distribution width	J:211773
Il6ra^{tm1.1(IL6R)Csk}/Il6ra^{tm1.1(IL6R)Csk} involves: 129S6/SvEvTac * C57BL/6	abnormal circulating serum amyloid protein level	J:207264
Il6ra^tm1.1Drew/Il6ra^tm1.1Drew involves: C57BL/6 * C57BL/6N * SJL	no abnormal phenotype detected	J:160966
Il6ra^tm1.1Drew/Il6ra^tm1.1Drew Lyz2^tm1(cre)Ifo/Lyz2⁺ involves: C57BL/6 * C57BL/6N * SJL	normal immune system phenotype	J:160966
Il6ra^tm1.1Drew/Il6ra^tm1.1Drew Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: C57BL/6 * C57BL/6N * SJL	decreased acute inflammation	J:160966
	normal homeostasis/metabolism phenotype	J:160966
Il6ra^tm1.1Drew/Il6ra^tm1.1Drew Tg(GFAP-cre)8Gtm/0 involves: C57BL/6 * C57BL/6N * CBA	abnormal emotion/affect behavior	J:211914
	abnormal head movements	J:211914
	normal behavior/neurological phenotype	J:211914
	normal nervous system phenotype	J:211914
	preweaning lethality, incomplete penetrance	J:211914
Il6ra^tm1.1Jcbr/Il6ra^tm1.1Jcbr Lyz2^tm1(cre)Ifo/Lyz2⁺ involves: 129P2/OlaHsd * C57BL/6	decreased circulating interleukin-1 beta level	J:188445
	decreased circulating tumor necrosis factor level	J:188445
	decreased susceptibility to parasitic infection	J:188445
Il6ra^tm1.1Jcbr/Il6ra^tm1.1Jcbr Tg(Alb1-cre)7Gsc/0 involves: C57BL/6 * FVB/N	abnormal glycogen homeostasis	J:166367
	normal adipose tissue phenotype	J:166367
	normal behavior/neurological phenotype	J:166367
	decreased adipocyte glucose uptake	J:166367
	decreased circulating interleukin-1 beta level	J:188445
	decreased circulating tumor necrosis factor level	J:188445
	decreased insulin secretion	J:166367
	decreased liver glycogen level	J:166367
	decreased susceptibility to parasitic infection	J:188445
	normal growth/size/body region phenotype	J:166367
	normal homeostasis/metabolism phenotype	J:166367
	impaired glucose tolerance	J:166367
	increased circulating interleukin-6 level	J:166367
	increased circulating tumor necrosis factor level	J:166367
	increased glycogen catabolism rate	J:166367
	increased insulin secretion	J:166367
	insulin resistance	J:166367
Il6ra^tm1.2Drew/Il6ra^tm1.2Drew involves: C57BL/6 * C57BL/6N * FVB/N * SJL	abnormal inflammatory response	J:160966
	abnormal wound healing	J:160966
Il6ra^tm1.2Jcbr/Il6ra^tm1.2Jcbr involves: C57BL/6	decreased circulating interleukin-1 beta level	J:188445
	decreased circulating tumor necrosis factor level	J:188445
	decreased hepatocyte proliferation	J:202764
	decreased incidence of tumors by chemical induction	J:202764
	decreased susceptibility to parasitic infection	J:188445
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:188445
	decreased tumor growth/size	J:202764
	normal growth/size/body region phenotype	J:202764
	increased circulating aspartate transaminase level	J:202764
	increased hepatocyte apoptosis	J:202764
	liver inflammation	J:202764
Il6ra^tm1Saj/Il6ra^tm1Saj involves: 129P2/OlaHsd * C57BL/6J	abnormal CD4-positive, alpha-beta T cell physiology	J:159479

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/09/2024 MGI 6.23